We’re introducing three powerful, interconnected tools that make it easier, faster, and more precise to diagnose and manage familial hypercholesterolaemia (FH). Built with input from patients, families and clinicians, these innovations are helping shape the future of cardiovascular health.
What is it?
The chip array is a compact, high-powered diagnostic tool that can scan your DNA for thousands of genetic markers linked to FH — all in one go. Think of it as a medical “microchip” that helps identify the inherited causes of high cholesterol.
What does it do?
Why it matters:
Today, many people with FH go undiagnosed until much later in life. This chip speeds up the process, catching risks earlier — especially in children and young adults — so they can get the care they need sooner.
What is it?
A biomarker is a biological signal — something measurable in your body that tells us about your health. This signature biomarker assay looks at how your white blood cells (leukocytes) take in and store fats, revealing how your body handles cholesterol at the cellular level.
What does it do?
Why it matters:
Not all people with FH respond the same way to treatment. This test helps clinicians decide who needs stronger therapies and who can do well with standard options — avoiding guesswork and getting better results, faster.
What is it?
This tool uses explainable artificial intelligence (AI) to combine and analyse a wide range of data — from your genetics and lab results to lifestyle factors and imaging. Unlike traditional “black box” AI, this system shows you how it reached its conclusions, in ways both patients and clinicians can understand.
What does it do?
Why it matters:
This tool bridges the gap between complex science and everyday healthcare. It gives patients real insight into their risks and options — enabling shared decisions with their care team based on trust and transparency.
These three tools work best in combination, but each is powerful on its own:
Together, they offer a new standard in FH care — proactive, personalised, and people-centred.